A wholly owned entity of Siemens Healthcare Diagnostics Inc. and based in Berkeley, California, SCL is uniquely positioned to provide high-complexity testing services for referring laboratory customers and innovative laboratory developed test (LDT) development to help pharmaceutical companies realize the potential of companion diagnostics. SCL has been certified under the Clinical Laboratory Improvement Amendments (CLIA) since 1994, accredited through the College of American Pathologists (CAP), and licensed in all U.S. states that require state-specific licensing. SCL has been a provider of accurate, reliable reference and back-up testing services for Siemens U.S. laboratory customers for over 18 years.
As an active participant in the California clinical laboratory community, SCL also provides:
- Professional, continuing education to support relicensure requirements for Clinical Laboratory Scientists
- Formal, California state-sponsored internship programs for the licensure of Clinical Genetic Molecular Biologist Scientists.
SCL has a growing track record of partnerships with pharmaceutical companies for companion diagnostics solutions, including ViiV Healthcare and Tocagen Inc. and continues to pursue leading-edge co-development opportunities.
“Our partnership with Siemens Healthcare Diagnostics is a valuable part of our commitment to addressing patient needs through developing innovative treatment approaches,” says Dr. John Pottage, Chief Scientific and Medical Officer, ViiV Healthcare. Dr. Harry E. Gruber, CEO of Tocagen Inc., agrees. “We believe that developing the necessary diagnostic tests with the right diagnostic partner is an important component for [our] successful commercialization.”